{"name":"Third Rock Ventures","permalink":"third-rock-ventures-2","crunchbase_url":"http://www.crunchbase.com/financial-organization/third-rock-ventures-2","homepage_url":"http://www.thirdrockventures.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"(617) 585-2000 ","description":"","email_address":"","number_of_employees":null,"founded_year":2007,"founded_month":null,"founded_day":null,"tag_list":"life-science-companies, biotechnology, pharmaceutical","alias_list":"","created_at":"Thu Jun 25 18:16:44 UTC 2009","updated_at":"Fri Jun 26 18:25:13 UTC 2009","overview":"<p>Third Rock Ventures invests in transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace.</p>","image":{"available_sizes":[[[150,78],"assets/images/resized/0005/0700/50700v1-max-150x150.png"],[[205,107],"assets/images/resized/0005/0700/50700v1-max-250x250.png"],[[205,107],"assets/images/resized/0005/0700/50700v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"HQ","address1":"29 Newbury Street; 3rd Floor","address2":"","zip_code":"02116","city":"Boston","state_code":"MA","country_code":"USA","latitude":42.7993567,"longitude":-70.808825}],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"Mark","last_name":"Levin","permalink":"mark-levin","image":null}},{"is_past":false,"title":"COO","person":{"first_name":"Kevin","last_name":"Starr","permalink":"kevin-starr","image":null}},{"is_past":false,"title":"Venture Partner","person":{"first_name":"Steven","last_name":"Paul","permalink":"steven-paul","image":null}},{"is_past":false,"title":"Entrepreneur-in-residence","person":{"first_name":"Keith","last_name":"Dionne","permalink":"keith-dionne","image":null}},{"is_past":false,"title":"Entrepreneur-In-Residence","person":{"first_name":"Ben","last_name":"Askew","permalink":"ben-askew","image":null}}],"investments":[{"funding_round":{"round_code":"a","source_url":"http://www.xconomy.com/seattle/2008/10/30/alnara-pharmaceuticals-inc-obtains-20000000-series-a-round/","source_description":"Alnara Pharmaceuticals Inc Obtains $20,000,000 Series A Round","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":10,"funded_day":30,"company":{"name":"Alnara Pharmaceuticals","permalink":"alnara-pharmaceuticals","image":{"available_sizes":[[[150,35],"assets/images/resized/0005/0698/50698v1-max-150x150.png"],[[250,58],"assets/images/resized/0005/0698/50698v1-max-250x250.png"],[[260,61],"assets/images/resized/0005/0698/50698v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.constellationpharma.com/pr_081309.htm","source_description":"Constellation Pharmaceuticals, Inc.  Closes $17 Million in Funding ","raised_amount":17200000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":13,"company":{"name":"Constellation Pharmaceuticals","permalink":"constellation-pharmaceuticals","image":{"available_sizes":[[[150,62],"assets/images/resized/0006/2182/62182v1-max-150x150.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-250x250.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2009/12/afferent-pharmaceuticals-closes-23m.html","source_description":"Afferent Pharmaceuticals Closes $23M Series A Financing Round","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":16,"company":{"name":"Afferent Pharmaceuticals","permalink":"afferent-pharmaceuticals","image":{"available_sizes":[[[150,42],"assets/images/resized/0007/6112/76112v1-max-150x150.png"],[[250,71],"assets/images/resized/0007/6112/76112v1-max-250x250.png"],[[263,75],"assets/images/resized/0007/6112/76112v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/eleven-biotherapeutics-inc-series-a-35m/","source_description":"Eleven Biotherapeutics, Inc.: Series A $35M","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":9,"company":{"name":"Eleven Biotherapeutics","permalink":"eleven-biotherapeutics","image":{"available_sizes":[[[150,35],"assets/images/resized/0007/9609/79609v1-max-150x150.jpg"],[[250,59],"assets/images/resized/0007/9609/79609v1-max-250x250.jpg"],[[360,85],"assets/images/resized/0007/9609/79609v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/genetix-raises-35m-advance-gene-therapies/2010-03-11?utm_medium=rss&utm_source=rss","source_description":"Genetix raises $35M to advance gene therapies","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":12,"company":{"name":"bluebird bio","permalink":"genetix-pharmaceuticals","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/0169/80169v2-max-150x150.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-250x250.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/zafgen-inc-series-b-81m/","source_description":"ZafGen, Inc.: Series B $8.1M","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":29,"company":{"name":"Zafgen","permalink":"zafgen","image":{"available_sizes":[[[150,56],"assets/images/resized/0008/0171/80171v1-max-150x150.jpg"],[[250,93],"assets/images/resized/0008/0171/80171v1-max-250x250.jpg"],[[321,120],"assets/images/resized/0008/0171/80171v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/10/foundation-medicine-closes-33-5m-expanded-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Foundation Medicine Closes $33.5M Expanded Series A Financing","raised_amount":33500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":18,"company":{"name":"Foundation Medicine","permalink":"foundation-medicine","image":{"available_sizes":[[[150,84],"assets/images/resized/0013/4432/134432v1-max-150x150.png"],[[214,120],"assets/images/resized/0013/4432/134432v1-max-250x250.png"],[[214,120],"assets/images/resized/0013/4432/134432v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/ablexis-llc-series-a-12m/","source_description":"Ablexis, LLC: Series A $12M","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":4,"company":{"name":"Ablexis","permalink":"ablexis","image":{"available_sizes":[[[150,30],"assets/images/resized/0008/9828/89828v1-max-150x150.jpg"],[[223,46],"assets/images/resized/0008/9828/89828v1-max-250x250.jpg"],[[223,46],"assets/images/resized/0008/9828/89828v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/constellation-pharmaceuticals-inc-series-b-48m/","source_description":"Constellation Pharmaceuticals, Inc.: Series B $4.8M","raised_amount":4800000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":7,"company":{"name":"Constellation Pharmaceuticals","permalink":"constellation-pharmaceuticals","image":{"available_sizes":[[[150,62],"assets/images/resized/0006/2182/62182v1-max-150x150.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-250x250.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/09/cytomx-therapeutics-completes-30m.html","source_description":"CytomX Therapeutics Completes $30M Series B Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":23,"company":{"name":"CytomX Therapeutics","permalink":"cytomx-therapeutics","image":{"available_sizes":[[[150,51],"assets/images/resized/0010/3203/103203v1-max-150x150.jpg"],[[250,85],"assets/images/resized/0010/3203/103203v1-max-250x250.jpg"],[[293,100],"assets/images/resized/0010/3203/103203v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/press-releases/ninepoint-medical-completes-33-million-series-financing","source_description":"NinePoint Medical Completes $33 Million Series A Financing","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":14,"company":{"name":"NinePoint Medical","permalink":"ninepoint-medical","image":{"available_sizes":[[[150,83],"assets/images/resized/0010/6204/106204v1-max-150x150.jpg"],[[250,138],"assets/images/resized/0010/6204/106204v1-max-250x250.jpg"],[[285,158],"assets/images/resized/0010/6204/106204v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/01/panoptica-raises-30m-in-series.html","source_description":"PanOptica Raises $30m in Series A Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":4,"company":{"name":"PanOptica","permalink":"panoptica","image":{"available_sizes":[[[150,56],"assets/images/resized/0011/6246/116246v1-max-150x150.png"],[[250,93],"assets/images/resized/0011/6246/116246v1-max-250x250.png"],[[277,104],"assets/images/resized/0011/6246/116246v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.blueprintmedicines.com/pdf/Blueprint-Launch-PR.pdf","source_description":"Blueprint Medicines Secures $40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":11,"company":{"name":"Blueprint Medicines","permalink":"blueprint-medicines","image":{"available_sizes":[[[150,31],"assets/images/resized/0013/0131/130131v1-max-150x150.png"],[[250,52],"assets/images/resized/0013/0131/130131v1-max-250x250.png"],[[300,63],"assets/images/resized/0013/0131/130131v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://eon.businesswire.com/news/eon/20110413005035/en/TARIS/Third-Rock-Ventures/Series-B","source_description":"TARIS Closes $18.3 Million Series B Financing","raised_amount":18300000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":13,"company":{"name":"TARIS Biomedical","permalink":"taris-biomedical","image":{"available_sizes":[[[150,54],"assets/images/resized/0005/1078/51078v1-max-150x150.jpg"],[[219,80],"assets/images/resized/0005/1078/51078v1-max-250x250.jpg"],[[219,80],"assets/images/resized/0005/1078/51078v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.live-pr.com/en/bluebird-bio-secures-additional-r1048856638.htm","source_description":"bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team ","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":20,"company":{"name":"bluebird bio","permalink":"genetix-pharmaceuticals","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/0169/80169v2-max-150x150.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-250x250.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.7sbio.com/news/Financing-press-release-05-11-11.html","source_description":"Seventh Sense Biosystems Secures $4.5M from $10M Series A Offering","raised_amount":4500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":11,"company":{"name":"Seventh Sense Biosystems","permalink":"seventh-sense-biosystems","image":{"available_sizes":[[[150,46],"assets/images/resized/0013/4102/134102v1-max-150x150.jpg"],[[250,76],"assets/images/resized/0013/4102/134102v1-max-250x250.jpg"],[[277,85],"assets/images/resized/0013/4102/134102v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/06/constellation-pharmaceuticals-raises-15m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Constellation Pharmaceuticals Raises $15M in Series B Financing","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":6,"company":{"name":"Constellation Pharmaceuticals","permalink":"constellation-pharmaceuticals","image":{"available_sizes":[[[150,62],"assets/images/resized/0006/2182/62182v1-max-150x150.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-250x250.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://financial.businessinsider.com/siliconalleymedia.clusterstock/news/read?GUID=18857212","source_description":"Lotus Tissue Repair, Inc. Secures $26 Million Series A Financing to Develop First-in-Class Protein Replacement Therapy for Dystrophic Epidermolysis Bullosa ","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":30,"company":{"name":"Lotus Tissue Repair","permalink":"lotus-tissue-repair","image":{"available_sizes":[[[150,53],"assets/images/resized/0014/1937/141937v1-max-150x150.jpg"],[[199,71],"assets/images/resized/0014/1937/141937v1-max-250x250.jpg"],[[199,71],"assets/images/resized/0014/1937/141937v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://eon.businesswire.com/news/eon/20110707005275/en/Series-C-Financing/Obesity-drug/bariatric-surgery","source_description":"Zafgen Secures $33 Million Series C Financing","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":7,"company":{"name":"Zafgen","permalink":"zafgen","image":{"available_sizes":[[[150,56],"assets/images/resized/0008/0171/80171v1-max-150x150.jpg"],[[250,93],"assets/images/resized/0008/0171/80171v1-max-250x250.jpg"],[[321,120],"assets/images/resized/0008/0171/80171v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/10/sage-therapeutics-raises-35m-series-funding-rock-ventures.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"SAGE Therapeutics Raises $35M in Series A Funding from Third Rock Ventures","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":18,"company":{"name":"SAGE Therapeutics","permalink":"sage-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0015/8645/158645v1-max-150x150.jpg"],[[180,60],"assets/images/resized/0015/8645/158645v1-max-250x250.jpg"],[[180,60],"assets/images/resized/0015/8645/158645v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/10/topica-pharmaceuticals-raises-27m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"TOPICA Pharmaceuticals Raises $27M in Series B Funding","raised_amount":27000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":18,"company":{"name":"Topica Pharmaceuticals","permalink":"topica","image":{"available_sizes":[[[131,102],"assets/images/resized/0015/8649/158649v1-max-150x150.jpg"],[[131,102],"assets/images/resized/0015/8649/158649v1-max-250x250.jpg"],[[131,102],"assets/images/resized/0015/8649/158649v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/11/allena-pharmaceuticals-raises-15m-series-venture-capital-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Allena Pharmaceuticals Raises $15M in Series A Venture Capital Financing","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":16,"company":{"name":"Allena Pharmaceuticals","permalink":"allena-pharmaceuticals","image":{"available_sizes":[[[150,47],"assets/images/resized/0016/2638/162638v1-max-150x150.jpg"],[[199,63],"assets/images/resized/0016/2638/162638v1-max-250x250.jpg"],[[199,63],"assets/images/resized/0016/2638/162638v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2011/11/agios-pharmaceuticals-raises-78m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Agios Pharmaceuticals Raises $78M in Series C Financing","raised_amount":78000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":17,"company":{"name":"Agios Pharmaceuticals","permalink":"agios-pharmaceuticals","image":{"available_sizes":[[[150,33],"assets/images/resized/0007/1525/71525v1-max-150x150.png"],[[175,39],"assets/images/resized/0007/1525/71525v1-max-250x250.png"],[[175,39],"assets/images/resized/0007/1525/71525v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.embertx.com/files/EmberLaunch.pdf","source_description":"Third Rock Ventures Launches Ember Therapeutics Secures $34 Million Series A to Accelerate Drug Discovery & Development","raised_amount":34000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":12,"funded_day":15,"company":{"name":"Ember Therapeutics","permalink":"ember-therapeutics","image":{"available_sizes":[[[150,49],"assets/images/resized/0016/6621/166621v1-max-150x150.png"],[[210,69],"assets/images/resized/0016/6621/166621v1-max-250x250.png"],[[210,69],"assets/images/resized/0016/6621/166621v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/01/warp-drive-bio-raises-125m.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Warp Drive Bio Raises $125M","raised_amount":125000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":11,"company":{"name":"Warp Drive Bio","permalink":"warp-drive-bio","image":{"available_sizes":[[[150,42],"assets/images/resized/0016/9776/169776v1-max-150x150.png"],[[250,71],"assets/images/resized/0016/9776/169776v1-max-250x250.png"],[[352,100],"assets/images/resized/0016/9776/169776v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/03/kala-pharmaceuticals-raises-6-2m-equity-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Kala Pharmaceuticals Raises $6.2M in Equity Financing","raised_amount":6200000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":14,"company":{"name":"Kala Pharmaceuticals","permalink":"kala-pharmaceuticals","image":{"available_sizes":[[[150,66],"assets/images/resized/0017/8187/178187v1-max-150x150.jpg"],[[250,110],"assets/images/resized/0017/8187/178187v1-max-250x250.jpg"],[[253,112],"assets/images/resized/0017/8187/178187v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/04/alcresta-raises-10m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Alcresta Raises $10M in Series A Financing","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":17,"company":{"name":"Alcresta","permalink":"alcresta","image":{"available_sizes":[[[150,33],"assets/images/resized/0018/4793/184793v1-max-150x150.jpg"],[[248,56],"assets/images/resized/0018/4793/184793v1-max-250x250.jpg"],[[248,56],"assets/images/resized/0018/4793/184793v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.masshightech.com/stories/2012/05/07/daily15-Eleven-Biotherapeutics-rakes-in-20M-fundraise.html","source_description":"Eleven Biotherapeutics rakes in $20M fundraise","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":8,"company":{"name":"Eleven Biotherapeutics","permalink":"eleven-biotherapeutics","image":{"available_sizes":[[[150,35],"assets/images/resized/0007/9609/79609v1-max-150x150.jpg"],[[250,59],"assets/images/resized/0007/9609/79609v1-max-250x250.jpg"],[[360,85],"assets/images/resized/0007/9609/79609v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/06/igenica-raises-33m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Igenica Raises $33M in Series C Funding","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":12,"company":{"name":"Igenica","permalink":"igenica","image":{"available_sizes":[[[150,65],"assets/images/resized/0009/0611/90611v1-max-150x150.jpg"],[[250,109],"assets/images/resized/0009/0611/90611v1-max-250x250.jpg"],[[265,116],"assets/images/resized/0009/0611/90611v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.rhythmtx.com/NEWS/releases/061312.html","source_description":"Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":13,"company":{"name":"Rhythm Pharmaceuticals","permalink":"rhythm-pharmaceuticals","image":{"available_sizes":[[[150,70],"assets/images/resized/0008/0469/80469v10-max-150x150.jpg"],[[168,79],"assets/images/resized/0008/0469/80469v10-max-250x250.jpg"],[[168,79],"assets/images/resized/0008/0469/80469v10-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/06/global-blood-therapeutics-raises-40-7m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Global Blood Therapeutics Raises $40.7M in Series A Financing","raised_amount":40700000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":14,"company":{"name":"Global Blood Therapeutics","permalink":"global-blood-therapeutics","image":{"available_sizes":[[[150,46],"assets/images/resized/0019/5484/195484v1-max-150x150.jpg"],[[250,78],"assets/images/resized/0019/5484/195484v1-max-250x250.jpg"],[[298,93],"assets/images/resized/0019/5484/195484v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://in.finance.yahoo.com/news/bluebird-bio-secures-60-million-103000423.html","source_description":"bluebird bio Secures $60 Million in Oversubscribed Financing","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":25,"company":{"name":"bluebird bio","permalink":"genetix-pharmaceuticals","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/0169/80169v2-max-150x150.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-250x250.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/09/foundation-medicine-closes-42-5m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Foundation Medicine Closes $42.5M Series B Funding","raised_amount":42500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":20,"company":{"name":"Foundation Medicine","permalink":"foundation-medicine","image":{"available_sizes":[[[150,84],"assets/images/resized/0013/4432/134432v1-max-150x150.png"],[[214,120],"assets/images/resized/0013/4432/134432v1-max-250x250.png"],[[214,120],"assets/images/resized/0013/4432/134432v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/09/myokardia-raises-38m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"MyoKardia Raises $38M in Series A Financing","raised_amount":38000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":20,"company":{"name":"MyoKardia","permalink":"myokardia","image":{"available_sizes":[[[150,35],"assets/images/resized/0021/2366/212366v1-max-150x150.png"],[[250,58],"assets/images/resized/0021/2366/212366v1-max-250x250.png"],[[308,72],"assets/images/resized/0021/2366/212366v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/10/cibiem-raises-10m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Cibiem Raises $10M in Series A Financing","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":17,"company":{"name":"Cibiem","permalink":"cibiem","image":{"available_sizes":[[[150,55],"assets/images/resized/0021/6153/216153v1-max-150x150.jpg"],[[250,91],"assets/images/resized/0021/6153/216153v1-max-250x250.jpg"],[[261,96],"assets/images/resized/0021/6153/216153v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.pehub.com/174484/rhythm-adds-8m-cap-series-b-33m/","source_description":"Rhythm Adds $8M to Cap Series B at $33M","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":27,"company":{"name":"Rhythm Pharmaceuticals","permalink":"rhythm-pharmaceuticals","image":{"available_sizes":[[[150,70],"assets/images/resized/0008/0469/80469v10-max-150x150.jpg"],[[168,79],"assets/images/resized/0008/0469/80469v10-max-250x250.jpg"],[[168,79],"assets/images/resized/0008/0469/80469v10-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.masshightech.com/stories/2012/12/03/daily18-Obesity-drug-developer-Zafgen-raises-21M.html","source_description":"Obesity drug developer Zafgen raises $21M","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":12,"funded_day":4,"company":{"name":"Zafgen","permalink":"zafgen","image":{"available_sizes":[[[150,56],"assets/images/resized/0008/0171/80171v1-max-150x150.jpg"],[[250,93],"assets/images/resized/0008/0171/80171v1-max-250x250.jpg"],[[321,120],"assets/images/resized/0008/0171/80171v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[{"description":"Third Rock Ventures announced today that it has closed on its oversubscribed Fund II, raising $426 million.","stoned_year":2010,"stoned_month":9,"stoned_day":13,"source_url":"http://www.masshightech.com/stories/2010/09/13/daily2-Third-Rock-fund-hits-426-million.html","source_text":null,"source_description":"Third Rock fund hits $426 million","stoneable_type":"FinancialOrg","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Third Rock Ventures","permalink":"third-rock-ventures-2"}},{"description":"Robert Kamen, a former executive-in-residence at Oxford BioScience Partners, has joined life sciences-focused venture capital firm Third Rock Ventures LLC in the same role","stoned_year":2010,"stoned_month":11,"stoned_day":10,"source_url":"http://www.masshightech.com/stories/2010/11/08/daily26-Third-Rock-Ventures-adds-biologics-expert-Kamen.html","source_text":null,"source_description":"Third Rock Ventures adds biologics expert Kamen","stoneable_type":"FinancialOrg","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Third Rock Ventures","permalink":"third-rock-ventures-2"}}],"providerships":[],"funds":[{"name":"Fund II","funded_year":2010,"funded_month":9,"funded_day":13,"raised_amount":426000000,"raised_currency_code":"USD","source_url":"http://www.finsmes.com/2010/09/third-rock-ventures-closes-426m-venture.html","source_description":"Third Rock Ventures Closes $426M Venture Capital Fund"}],"video_embeds":[],"external_links":[]}